The Peptide Boom Is Getting Out of Hand
There’s no ambiguity about who Vyleesi is for. The prescription drug, commonly referred to as female Viagra, boosts the libido of women experiencing hypoactive-sexual-desire disorder, a condition in which lack of interest in sex causes distress. When Vyleesi was approved in 2019, an FDA official announced that it was evidence of the agency’s “commitment to protect and advance the health of women.”
TL;DR
- Vyleesi, a drug approved for hypoactive sexual desire disorder in women, is being used by men, sometimes obtained without a prescription through online retailers.
- Americans are accessing a variety of unregulated drugs, including banned substances for athletic recovery and unapproved drugs for weight loss, often through 'research use only' disclaimers.
- Online pharmacies and compounding pharmacies are offering 'personalized' medications with experimental additives, bypassing FDA regulation for safety, quality, or efficacy.
- Peptides, compounds mimicking hormones, have gained popularity among fitness enthusiasts and biohackers for purported benefits like muscle gain and increased focus.
- The growing market for compounded drugs, particularly for weight loss, is driven by accessibility and cost, though these products lack FDA oversight.
- The FDA faces challenges in regulating the widespread availability of potentially dangerous experimental drugs, described as a 'whack-a-mole' game.
- Concerns exist about the safety and efficacy of experimental drugs, with little scientific research to support anecdotal claims.
- Robert F. Kennedy Jr. has indicated plans to make certain peptides more accessible, aligning with a 'medical freedom' approach despite regulatory concerns.